![]() |
市場調查報告書
商品編碼
1666251
亞太地區乾眼產品市場預測至 2031 年 - 區域分析 - 按產品、劑型、類型和配銷通路Asia Pacific Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel |
2023年亞太地區乾眼症產品市值為11.0146億美元,預計2031年將達到16.4184億美元;預計 2023 年至 2031 年的複合年成長率為 5.1%。
提高眼部護理意識的措施推動亞太乾眼產品市場發展
近年來,人們採取了各種措施來提高對眼疾的認知和教育,促使患者獲得合適的藥物和治療。例如,作為可避免失明計畫 (ABP)(於 2021 年啟動)的一部分,諾華於 2022 年與撒哈拉以南非洲和東南亞的合作夥伴合作,讓這些國家能夠獲得其眼部護理產品。
國際防盲機構(IAPB)於2022年發起了「愛護你的眼睛」全球運動,以提高人們對眼健康社會經濟重要性的認知。該活動呼籲各國政府和全球機構支持眼健康。 IAPB 重點關注印度和世界各地的計劃和舉措,這些計劃和舉措重點是提供方便、可用且價格合理的眼科護理。 「愛護眼睛」計畫也呼籲改變法規並投入資金,到2030年讓人們能夠獲得、獲得並且負擔得起眼部保健服務。
2022 年 12 月,防盲研究組織選定猶他大學約翰·A·莫蘭眼科中心,向其提供每年 115,000 美元的無限制資助,用於支持眼科研究。截至 2021 年 12 月,美國國立衛生研究院 (NIH) 支持印度阿拉文眼科醫院與家樂氏眼科中心建立合作夥伴關係,為眼科保健專業人員制定臨床研究培訓計畫。作為此項計劃的一部分,美國國立衛生研究院撥款 110 萬美元支持安娜堡(美國)的培訓項目,並為參與者提供種子資金。此外,2020年印度-美國合作視覺研究計畫致力於推進科學技術,以了解、預防和治療致盲視覺障礙、眼部疾病及其相關併發症。印度生物技術部和美國國家眼科研究所資助了這項研究計畫。
因此,增加用於眼部保健研究的資金和加強宣傳眼保健意識的力度可能會在未來幾年為乾眼症產品市場創造新的機會。
亞太乾眼產品市場概覽
亞太乾眼產品市場分為中國、印度、日本、韓國、澳洲和亞太其他地區。可能推動該地區市場成長的因素包括因長時間使用電腦導致年輕人乾眼症發病率不斷上升、政府對眼部保健的支持不斷增加、以及眼科解決方案的不斷發展。根據美國國立衛生研究院的數據,在中國,每年約有 20-30% 的人被診斷出患有乾眼症。中國乾眼產品市場競爭相當激烈,國內外藥廠都有參與。 Novaliq與江蘇恆瑞醫藥建立策略合作,共同生產、開發和商業化用於治療乾眼症的NOV03。 2021年12月,恆瑞在治療瞼板腺功能障礙相關乾眼症的SHR8058(NOV03)關鍵3期臨床試驗中取得正面成果;該試驗在中國各地17個地點進行。該中國公司預計將在中國和東南亞地區分銷這些產品。
亞太乾眼產品市場營收及 2031 年預測(百萬美元)
亞太地區乾眼產品市場區隔
亞太乾眼產品市場分為產品、劑型、類型、配銷通路和國家。
根據產品,亞太乾眼產品市場分為人工淚液、抗發炎藥、淚點塞、促泌劑、口服歐米茄補充劑等。 2023 年,人工淚液佔據了亞太地區乾眼症產品市場的最大佔有率。此外,淚點塞部分又細分為可溶解和可拆卸。
就劑型而言,亞太乾眼症產品市場分為眼藥水、凝膠、膠囊及錠劑等。 2023 年,眼藥水部門佔據了亞太地區乾眼產品市場的最大佔有率。
根據類型,亞太乾眼症產品市場分為非處方藥和處方藥。 2023 年,OTC 部門佔據了亞太地區乾眼症產品市場的較大佔有率。
根據配銷通路,亞太乾眼產品市場分為零售藥局、醫院藥局和網路藥局。 2023 年,零售藥局部門佔據了亞太地區乾眼產品市場最大的佔有率。
根據國家/地區,亞太乾眼產品市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2023年,中國佔據亞太地區乾眼症產品市場的主導佔有率。
參天製藥有限公司、強生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、樂敦製藥有限公司、OCuSOFT Inc、博士倫醫療公司、艾伯維公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和愛爾康公司是亞太地區乾眼症產品市場的一些領先公司。
The Asia Pacific dry eye products market was valued at US$ 1,101.46 million in 2023 and is expected to reach US$ 1,641.84 million by 2031; it is estimated to register a CAGR of 5.1% from 2023 to 2031.
Increasing Initiatives for Eye Care Awareness Boost Asia Pacific Dry Eye Products Market
In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. For instance, as a part of the Avoidable Blindness Program (ABP) (launched in 2021), Novartis worked with its partners across Sub-Saharan Africa and Southeast Asia to access to its eye care products in 2022. ABP focuses on moderate to severe vision damage caused by glaucoma and retinal conditions that are responsible for a large proportion of preventable blindness.
The International Agency for the Prevention of Blindness (IAPB) launched the global campaign named "Love Your Eyes" in 2022 to raise awareness of the socioeconomic importance of eye health. The campaign calls upon governments and global institutions to support eye health. The IAPB emphasizes programs and initiatives in India and the world, which promptly focus on offering accessible, available, and affordable eye care. The "Love Your Eyes" program also calls for regulation changes and funding to make eye care accessible, available, and affordable by 2030.
In December 2022, Research to Prevent Blindness selected the John A. Moran Eye Center at the University of Utah for the unlimited annual grant of US$ 115,000 to support eye research. As of December 2021, the National Institutes of Health (NIH) supported a partnership between Aravind Eye Hospital (India) and Kellogg Eye Center to develop a clinical research training program for eyecare professionals. As a part of this initiative, the NIH awarded US$ 1.1 million to support training programs in Ann Arbor (US) and offered seed funding for the participants. In addition, the India-US Collaborative Vision Research Program 2020 focuses on advancing science and technology to understand, prevent, and treat blinding visual disorders, eye diseases, and associated complications. The Indian Department of Biotechnology and the US National Eye Institute funded this research program.
Thus, increasing funds for eyecare research and rising initiatives to spread awareness about eye care are likely to create new opportunities in the dry eye product market in the coming years.
Asia Pacific Dry Eye Products Market Overview
The Asia Pacific dry eye products market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The factors that are likely to contribute to the market growth in this region include the increasing incidence of DED among young people due to prolonged usage of computers, growing government support for eye health, and ongoing developments in ophthalmic solutions. According to NIH, in China, ~20-30% of people are diagnosed with dry eye conditions every year. The dry eye products market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. Novaliq has established a strategic cooperation with Jiangsu Hengrui Pharmaceuticals to manufacture, develop, and commercialize NOV03 for the treatment of dry eye disease. In December 2021, Hengrui obtained positive outcomes from the critical Phase 3 clinical trial of SHR8058 (NOV03) for the treatment of dry eye disease linked with meibomian gland dysfunction; the trial was conducted at 17 sites across China. The Chinese firm is expected to distribute these products across China and Southeast Asia.
Asia Pacific Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Dry Eye Products Market Segmentation
The Asia Pacific dry eye products market is categorized into product, dosage form, type, distribution channel, and country.
Based on product, the Asia Pacific dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest Asia Pacific dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.
In terms of dosage form, the Asia Pacific dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest Asia Pacific dry eye products market share in 2023.
By type, the Asia Pacific dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger Asia Pacific dry eye products market share in 2023.
Based on distribution channel, the Asia Pacific dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest Asia Pacific dry eye products market share in 2023.
Based on country, the Asia Pacific dry eye products market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dry eye products market share in 2023.
Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG are some of the leading companies operating in the Asia Pacific dry eye products market.